Targeting EMT in cancer with repurposed metabolic inhibitors

V Ramesh, T Brabletz, P Ceppi - Trends in cancer, 2020 - cell.com
Epithelial-to-mesenchymal transition (EMT) determines the most lethal features of cancer,
metastasis formation and chemoresistance, and therefore represents an attractive target in …

Epigenetics in cancer stem cells

TB Toh, JJ Lim, EKH Chow - Molecular cancer, 2017 - Springer
Compelling evidence have demonstrated that bulk tumors can arise from a unique subset of
cells commonly termed “cancer stem cells” that has been proposed to be a strong driving …

ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance

P Zhang, Y Sun, L Ma - Cell cycle, 2015 - Taylor & Francis
Zinc finger E-box binding homeobox 1 (ZEB1) is a transcription factor that promotes tumor
invasion and metastasis by inducing epithelial-mesenchymal transition (EMT) in carcinoma …

ZEB1 drives epithelial-to-mesenchymal transition in lung cancer

JE Larsen, V Nathan, JK Osborne… - The Journal of …, 2016 - Am Soc Clin Investig
Increased expression of zinc finger E-box binding homeobox 1 (ZEB1) is associated with
tumor grade and metastasis in lung cancer, likely due to its role as a transcription factor in …

EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression

D Pradella, C Naro, C Sette, C Ghigna - Molecular cancer, 2017 - Springer
Epithelial-to-mesenchymal transition (EMT) is associated with metastasis formation as well
as with generation and maintenance of cancer stem cells. In this way, EMT contributes to …

[HTML][HTML] Epithelial-mesenchymal transitions in development and disease

JP Thiery, H Acloque, RYJ Huang, MA Nieto - cell, 2009 - cell.com
The epithelial to mesenchymal transition (EMT) plays crucial roles in the formation of the
body plan and in the differentiation of multiple tissues and organs. EMT also contributes to …

EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness

E Sánchez-Tilló, Y Liu, O de Barrios, L Siles… - Cellular and molecular …, 2012 - Springer
Cancer is a complex multistep process involving genetic and epigenetic changes that
eventually result in the activation of oncogenic pathways and/or inactivation of tumor …

Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

H Peinado, D Olmeda, A Cano - Nature reviews cancer, 2007 - nature.com
The molecular mechanisms that underlie tumour progression are still poorly understood, but
recently our knowledge of particular aspects of some of these processes has increased …

The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?

S Brabletz, T Brabletz - EMBO reports, 2010 - embopress.org
Epithelial‐to‐mesenchymal transition (EMT) is a fundamental process in development and
disease. Zinc‐finger enhancer binding (ZEB) transcription factors (ZEB1 and ZEB2) are …

A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment

LK Huynh, CJ Hipolito, P Ten Dijke - Biomolecules, 2019 - mdpi.com
Transforming growth factor (TGF)-β is a secreted multifunctional cytokine that signals via
plasma membrane TGF-β type I and type II receptors and intercellular SMAD transcriptional …